Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amibegron in Elderly Patients with Major Depressive Disorder
NCT00319709Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of amibegron in major depressive disorder (MDD), sponsored by Sanofi. Started Apr 2006; status: completed.
02
Drugs
amibegron
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00319709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319709.